You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 2 Next »

The Amgen REFRAME app provides easy access to reporting relating to patients that have osteoporosis risk factors and gives the users a simple view of the patient's risk and other relevant factors in one table.

The app will apply the following patients:

  • Patients over 70 years of age and never had a DXA, or have not had a DXA within the last 2 years

Or

  • Patients that have experienced a fracture since the age of 50


When a patient meeting one of the criteria above is opened in your clinical system, the app will become active and show a notification in a red circle:

n


Clicking on the app icon will open it in full screen and display all relevant information in a table view:


If there is no information in the patient record, only the name of the indicator will be displayed. If the information is available, it will be displayed in green.

The following columns will be displayed within the app and populated if the data is stored within the patients record in a coded format.


ItemColumn NameData Mapping

1

>70yrs and no DXA or >2yrs since last DXA

Y or blank (nothing displayed)

2

Experienced a fracture since age of 50

Y or blank (nothing displayed)

3

Osteoporosis

Y or blank (nothing displayed)

4

Minimum Trauma Fracture

Y or blank (nothing displayed)

5

Received bone active medication in the last 5yrs

Y or blank (nothing displayed)

6

Glucocorticoid drug class >7.5mg per day for >3 months

Y or blank (nothing displayed)

7

BMI <20

Y or blank (nothing displayed)

8

hyperthyroidism

Y or blank (nothing displayed)

9

Smoking

Smoking status from the clinical system or blank

10

Coeliac Disease

Y or blank (nothing displayed)

11

Primary Hyperparathyroidism

Y or blank (nothing displayed)

12

Previous treatment with aromatase inhibitor drug class

Y or blank (nothing displayed)

13

History of poor calcium intake

Y or blank (nothing displayed)

14

History of low vitamin D

Y or blank (nothing displayed)

15

Inflammatory conditions associated with bone loss

Y or blank (nothing displayed)

16

CKD

Please see below for details on this indicator

17

Diagnosis Sarcopenia

Y or blank (nothing displayed)

18>70yrs and no DXA or >5yrs since last DXAY or blank (nothing displayed)
19Lapsed Osteoporosis medication >12mths and <5yrsY or blank (nothing displayed)

CKD displays stages of CKD (indicated or diagnosed) as well as likelihood of the indication based on the extracted pathology
results.

  • Indicated Staging of CKD
  • Color code for the Clinical Action Plan to manage CKD

Patients on dialysis are displayed as 'level 5' CKD.

For this report CAT will ignore any diagnosis of Kidney disease and the displayed indicated stages are purely based on the
eGFR and ACR results in the patient record.

Colour codes and their meaning:

Red
•Clinical Action Plan to be monitored 1-3 monthly

Orange
•Clinical Action Plan to be monitored 3-6 monthly

Yellow
•Clinical Action Plan to be monitored 12 monthly

For more information refer to Kidney Health Australia web site and the CKD Guideline Booklet available at www.kidney.org.au
Detection of CKD requires follow up testing once an abnormal result is recorded. The outcome of 3 tests over a 3 month
period will inform a diagnosis. CAT4 is only using the most recent eGFR and ACR, not the last 3 results. This will

•inform a diagnosis if 3 tests have been done or
•flag that a patient should be recalled for follow up testing if there are not 3 results in the Patient Record.

For full details on the CKD stage calculation please see here: http://kidney.org.au/cms_uploads/docs/02_algorithm-for-inital-detection-of-ckd.pdf